Critical Illness / Generali Life Indonesia
Cristal Prime
CRISTAL Prime is the "money back if nothing happens" answer to CI insurance.
★ The Insurer’s Play
analytical interpretationWhy this product exists
To sell lump-sum protection against a small set of high-cost diagnoses — specifically, to capture whole-household budgets rather than single lives and capture the affluent / legacy-minded segment with larger case sizes.
What the insurer wants the agent to do
Steer the agent to bundle several family members onto one policy, attach and upsell supplementary riders, and qualify for higher-income, larger-sum cases.
Inferred from: family-package structurerider attachmentaffluent / legacy segmentSyariah / pilgrimage structuresavings / return-of-premium benefitpremium-waiver benefit
Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.
Who this fits — and who it doesn’t
✓ Fits when…
- Age 35–55, ideally 35–48 — the CI sweet spot where pre-existing exclusions are still manageable and the 15/20/25-year horizon covers peak CI-incidence years (40–65).
- Family history of a covered CI condition (cancer, heart disease, stroke) but currently healthy and underwritable.
- Already has separate term life or whole-life cover for legacy/income-replacement purposes — CRISTAL Prime is a single-purpose CI layer, not a primary life policy.
- Already has medical / hospitalisation insurance — understands CI cash and medical reimbursement are different products.
- Risk-averse, "I don't want to lose the premium" personality — the maturity return-of-premium is the structural feature that resonates with this customer. The customer who says "saya nggak mau premi hangus" is the target.
- Middle-affluent income — disposable Rp 5–15M/month for protection layer; sum assured Rp 300M–Rp 1B is the natural zone before the Rp 200M top-up cap compresses the ratio.
- Sees CI as a finite-window risk to be covered through working years, not a permanent need.
~ Borderline — qualify carefully
- Age 28–34 — premium is cheap, but the 25-year term ends at age 53–59, exactly when CI incidence is climbing fastest. Customer needs to understand renewal/reinsurance is not available at end-of-term; they will be uninsured at the moment they're most exposed.
- Age 56–60 — entry age is allowed (cap is 60) but the 25-year term may be unavailable depending on Generali underwriting; 15-year is the realistic option, and premium loads heavily. The product is not designed for late-career buyers.
- High-net-worth prospects looking at Rp 2B+ SA — the Rp 200M top-up cap means the effective CI benefit ratio degrades on large case sizes. Allianz Critical+ or a stacked CI architecture is usually a better fit at that case size.
- Sharia-preference customer — CRISTAL Prime is conventional. Generali's iSalaam or RIZQIA is the cross-sell.
✕ Not a fit when…
- Customer who needs life cover as the primary protection — the Rp 123M death benefit on Pak Surya's Rp 500M SA case shows the structure. CRISTAL Prime is not a life policy.
- Customer who has not yet bought medical / hospital coverage — sell them health first, then CI.
- Customer who expects CI premium waiver after diagnosis — CRISTAL Prime pays the lump sum and terminates. There is no waiver-and-continue option in this product; the policy ends on first CI claim.
- Customer who wants multi-stage CI payouts (early + major + waiver) — they want Allianz Critical+ or a similar staged-CI product, not CRISTAL Prime.
- Mass-market customer with monthly disposable below Rp 1.5M for protection layer — the Rp 3.3M annual premium minimum is the floor; below this the product economics do not work.
- Customer flagged as likely-lapse (income volatility, business stress, recent job loss) — the 0% surrender value in years 1–3 makes this unforgiving.
The trade-offs — when it wins, when it doesn’t
No product wins for everyone. Here’s when Cristal Prime is the right call — and when a different product is.
CUSTOMER FRAMES IT AS "PREMI TIDAK HANGUS"
CUSTOMER WANTS STAGED CI (EARLY + MAJOR + TERMINAL)
CUSTOMER WANTS PREMIUM WAIVER AFTER CI DIAGNOSIS
CUSTOMER WANTS CI COVER FOR LIFE, NOT JUST 15–25 YRS
CUSTOMER WANTS PURE PROTECTION, LOWEST PREMIUM
CUSTOMER CONFUSES CI WITH MEDICAL / HOSPITAL COVER
CUSTOMER HAS LARGE SUM ASSURED NEED (RP 2B+)
CUSTOMER IS 28–34, HEALTHY, WANTS CHEAP LONG COVER
CUSTOMER IS SHARIA- PREFERRING
Key facts
Coverage
- Sum assured: not disclosed on page
- Policy term: not disclosed on page
- Pricing: not disclosed on page
Target Customer
not disclosed on page
Key Features
- Perlindungan Jiwa Perlindungan Jiwa GEN Prime Link GEN Syariah Perlindungan Aman GEN Wealth GEN Proteksi Utama BeSmart Lite BeSmart Cemerlang Prime RAYA Pro Maxima RIZQIA iFLEXYGUARD iSalaam
- Kesehatan Kesehatan GEN MediCare Protection GEN HealthCare Protection Syariah GEN HealthCare Protection Generali Lite Healthcare Generali Lite HealthCare Syariah Generali HealthCare Solution
- Penyakit Kritis Penyakit Kritis MCI PRO Cristal Prime
- Pensiun Pensiun Bravo Individu Bravo Perusahaan
- Syariah Syariah GEN HealthCare Protection Syariah GEN Syariah Perlindungan Aman RAYA Pro Maxima RIZQIA iSalaam
⚠ Compliance red flags & mis-selling warnings
CI products carry distinct compliance risk versus life or medical products. These are the seven issues most likely to trigger an OJK complaint, a customer dispute, or a claim repudiation under 2026 conduct rules. Build agent training around avoiding all of them.
-
CI condition definitions are medical, not lay. “Cancer” in CRISTAL Prime (and every comparable CI product) means a histologically confirmed malignant tumour with characteristics defined by the policy. In-situ carcinomas, early-stage prostate cancer, and certain skin cancers are commonly excluded or partially paid. Customer must understand the difference between “the doctor said cancer” and “the policy definition of cancer.” Walk through the top 5 most-claimed conditions (cancer, heart attack, stroke, kidney failure, major surgery) at application stage.
-
Pre-existing condition exclusion plus waiting period. CRISTAL Prime excludes any CI condition arising during the waiting period and any condition that pre-existed the policy (unless specifically endorsed). The RIPLAY references “Masa Tunggu” without specifying a number in the section provided; the policy document itself is the binding source — confirm the exact waiting period with the customer on the SPAJ. Failing to disclose pre-existing conditions is the single most common cause of claim repudiation in Indonesian CI insurance.
-
Single-event payout and policy termination. CRISTAL Prime pays once and ends. Customer must understand: if they survive their first CI event, the policy is over and they have no remaining CI cover from this product. Sell this clearly. Customers who think “I have CI cover for 25 years” but expect cover to continue after a claim will complain at the second event.
-
Death benefit is not life insurance. The CRISTAL Prime death benefit during the term is 120–150% of total premiums paid — typically a fraction of the CI sum assured. Pak Surya’s Rp 500M CI SA pays Rp 123M on death — that is roughly 25% of the CI SA. Selling CRISTAL Prime as a “life and CI combo” is mis-selling. If the customer needs life cover, sell a term life or whole-life policy alongside.
-
CI cash is not medical reimbursement. Customer must understand CRISTAL Prime does not pay for hospital bills, doctor’s fees, chemotherapy, or surgery costs. It pays cash on diagnosis. The customer who thinks “I have CRISTAL Prime, my hospital bill is covered” will complain at the first hospitalisation. Always pair-sell with a medical / hospital policy or confirm the customer has one in force.
-
Return-of-premium framing creates ambiguity risk. “Premi kembali 150%” in marketing language can be heard as “investment return of 50% over 25 years,” which it is not. Over 25 years at any reasonable inflation rate, 150% of nominal premiums is a negative real return. The cash-back is a structural feature, not a yield. Document the customer’s understanding of nominal-vs-real explicitly on the SPAJ.
-
End-of-term re-insurability risk. At policy maturity the customer is 56–85 years old (depending on entry age and term length). At that age CI is hard or impossible to re-purchase. The customer who expects “I’ll just buy new CI cover at 60” needs to understand the practical reality: CI premiums at 60+ are prohibitive and underwriting is restrictive. Frame the term selection explicitly: CRISTAL Prime is CI cover for this window only; legacy CI needs come from a different product.
These compliance points are derived from OJK’s 2026 conduct rules on insurance product distribution (transparency, suitability assessment, documented customer understanding) and from general Indonesian CI product practice. They are not specific to Generali and apply equally to any comparable agency CI sale.
Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.
Expert · technical detail
How Critical Illness products differ
Still building · 77% coverageNo product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.
- Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
- Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
- Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
- Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
- TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.
Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)
Expert · full Strategic Brief
1. The 60-Second Pitch
CRISTAL Prime is the “money back if nothing happens” answer to CI insurance. It is a fixed-term (15/20/25-year) lump-sum CI policy with a short premium payment window (3/5/10 years) and a guaranteed return of 120% / 135% / 150% of total premiums paid at the end of the term if no claim occurs — paid as either a maturity benefit (insured survives), a death benefit (insured dies during term), or in proportional form on early surrender. The CI benefit is a single-event payout: on diagnosis of any of 66 covered conditions the policy pays 100% sum assured plus a 20% top-up (capped at Rp 200M) and terminates. There is no early-stage / major-stage staging, no premium waiver after CI diagnosis, and no whole-life tail. Structurally this is a CI-flavoured endowment — Generali is selling cash-back certainty wrapped in CI cover, not the multi-stage CI architecture that defines the Allianz Critical+ / TMLI tm-ci-guard premium tier.
In one line: Pay for 3, 5, or 10 years; if you get one of 66 critical illnesses anytime in the next 15–25 years, the policy pays 120% of your sum assured and ends. If nothing happens, you get 120–150% of your premiums back. The trade-off is single-event CI cover with no staging and no premium waiver after diagnosis.
2. Headline Numbers Decoded
The official Generali illustration in the RIPLAY uses Pak Surya, 31yo male, Rp 500M sum assured, 25-year term, 5-year PPT, Rp 16.445M annual premium. Decoded:
Critical insight for the agent narrative: the death benefit during the term is not life cover in any meaningful sense — it is just an early payout of the premium-return tail. A 31yo with a Rp 500M CI sum assured and only Rp 123M of death cover is structurally under-insured on the life leg. CRISTAL Prime customers need a separate term life or whole-life policy alongside. Pitching CRISTAL Prime as life insurance is mis-selling.
A second insight: the 20% top-up on CI payout is capped at Rp 200M, so the effective max CI benefit ratio compresses on larger sum assureds. At Rp 1B SA the CI payout is 120% (Rp 1.2B = Rp 1B + Rp 200M cap). At Rp 5B SA the CI payout is 104% (Rp 5B + Rp 200M cap) — the relative top-up shrinks materially on the affluent end.
TOTAL PREMIUM PAID (5 yrs)
Rp 82.225M
What Pak Surya hands Generali
during the 5-year payment
window.
CI BENEFIT IF DIAGNOSED
Rp 600M
(100% SA + 20% top-up,
capped Rp 200M on top-up)
Paid once on first covered
diagnosis; policy ends.
ANGIOPLASTY PARTIAL PAYOUT
Rp 50M (10% SA, cap Rp 200M)
Paid for the listed
angioplasty/invasive coronary
treatment item.
DEATH BENEFIT (DURING TERM)
Rp 123.3375M
Flat — equals 150% of total
premiums (25-yr term).
Note:~24.7% of sum assured. This is not life cover; it is premium-return-on-death.
MATURITY BENEFIT (YEAR 25,
NO CLAIM)
Rp 123.3375M
150% of total premiums paid.
Paid if insured survives the
full 25-year term.
CI BENEFIT MULTIPLE OF
PREMIUMS PAID
~7.3x
Rp 600M / Rp 82.2M total
premium. Strong if CI strikes
early; weakens with time as
opportunity cost of premium
rises.
SURRENDER VALUE — END YEAR 1–3
Rp 0
No cash value in the first
three policy years.
SURRENDER VALUE — END YEAR 5
Rp 8.2225M (~10% of premiums)
Paid-up; weak.
SURRENDER VALUE — END YEAR 10
Rp 32.89M (~40% of premiums)
SURRENDER VALUE — END YEAR 15
Rp 41.11M (~50% of premiums)
SURRENDER VALUE — END YEAR 25
Rp 123.3375M (150% of
premiums) — same as maturity
if held to term.
3. Ideal Customer Profile
Sweet Spot — CRISTAL Prime is genuinely a fit
-
Age 35–55, ideally 35–48 — the CI sweet spot where pre-existing exclusions are still manageable and the 15/20/25-year horizon covers peak CI-incidence years (40–65).
-
Family history of a covered CI condition (cancer, heart disease, stroke) but currently healthy and underwritable.
-
Already has separate term life or whole-life cover for legacy/income-replacement purposes — CRISTAL Prime is a single-purpose CI layer, not a primary life policy.
-
Already has medical / hospitalisation insurance — understands CI cash and medical reimbursement are different products.
-
Risk-averse, “I don’t want to lose the premium” personality — the maturity return-of-premium is the structural feature that resonates with this customer. The customer who says “saya nggak mau premi hangus” is the target.
-
Middle-affluent income — disposable Rp 5–15M/month for protection layer; sum assured Rp 300M–Rp 1B is the natural zone before the Rp 200M top-up cap compresses the ratio.
-
Sees CI as a finite-window risk to be covered through working years, not a permanent need.
Borderline Fit — Discuss but qualify
-
Age 28–34 — premium is cheap, but the 25-year term ends at age 53–59, exactly when CI incidence is climbing fastest. Customer needs to understand renewal/reinsurance is not available at end-of-term; they will be uninsured at the moment they’re most exposed.
-
Age 56–60 — entry age is allowed (cap is 60) but the 25-year term may be unavailable depending on Generali underwriting; 15-year is the realistic option, and premium loads heavily. The product is not designed for late-career buyers.
-
High-net-worth prospects looking at Rp 2B+ SA — the Rp 200M top-up cap means the effective CI benefit ratio degrades on large case sizes. Allianz Critical+ or a stacked CI architecture is usually a better fit at that case size.
-
Sharia-preference customer — CRISTAL Prime is conventional. Generali’s iSalaam or RIZQIA is the cross-sell.
Do Not Pitch
-
Customer who needs life cover as the primary protection — the Rp 123M death benefit on Pak Surya’s Rp 500M SA case shows the structure. CRISTAL Prime is not a life policy.
-
Customer who has not yet bought medical / hospital coverage — sell them health first, then CI.
-
Customer who expects CI premium waiver after diagnosis — CRISTAL Prime pays the lump sum and terminates. There is no waiver-and-continue option in this product; the policy ends on first CI claim.
-
Customer who wants multi-stage CI payouts (early + major + waiver) — they want Allianz Critical+ or a similar staged-CI product, not CRISTAL Prime.
-
Mass-market customer with monthly disposable below Rp 1.5M for protection layer — the Rp 3.3M annual premium minimum is the floor; below this the product economics do not work.
-
Customer flagged as likely-lapse (income volatility, business stress, recent job loss) — the 0% surrender value in years 1–3 makes this unforgiving.
4. Decision Framework — When CRISTAL Prime Wins, When It Doesn't
This section is competitive intelligence for Legacy Income agents. CRISTAL Prime is a Generali product; Legacy Income sells Allianz. The framework below is for competitive positioning when a prospect surfaces a CRISTAL Prime quote or asks about it, not for prescribing CRISTAL Prime.
Rule of thumb: if the customer’s first sentence contains “premi tidak hangus” (premium doesn’t expire / get wasted), “uang kembali” (money back), or “jaminan pengembalian” (guaranteed return), CRISTAL Prime is a competitive threat and the Legacy Income agent should reframe to staging and lifetime cover. If the customer’s first sentence contains “penyakit kritis seumur hidup” (CI for life), “early stage”, “tetap aktif setelah diagnosis” (still active after diagnosis), or “anak-anak” (children/legacy), CRISTAL Prime is the weaker structure and Allianz Critical+, Flexi CI on whole-life base, or LegacyPro (with CI waiver as base) wins on structural merit.
CUSTOMER FRAMES IT AS "PREMI TIDAK HANGUS"
CUSTOMER WANTS STAGED CI (EARLY + MAJOR + TERMINAL)
CUSTOMER WANTS PREMIUM WAIVER AFTER CI DIAGNOSIS
CUSTOMER WANTS CI COVER FOR LIFE, NOT JUST 15–25 YRS
CUSTOMER WANTS PURE PROTECTION, LOWEST PREMIUM
CUSTOMER CONFUSES CI WITH MEDICAL / HOSPITAL COVER
CUSTOMER HAS LARGE SUM ASSURED NEED (RP 2B+)
CUSTOMER IS 28–34, HEALTHY, WANTS CHEAP LONG COVER
CUSTOMER IS SHARIA- PREFERRING
5. Product Benchmarking — CRISTAL Prime vs the CI Category
The Indonesian critical-illness category contains 26 catalogued products (23 with PDFs extracted, 25 agency-channel). Per the May 2026 category-benchmarks computation, all four key quantitative metrics fall below the 60% coverage threshold (annual premium 17%, sum assured 26%, CI conditions count 39%, policy term 17%). This brief therefore relies on qualitative comparison drawn directly from the RIPLAY plus the documented category observations.
Confidence note: structural-dimension claims about CRISTAL Prime are high-confidence (drawn directly from RIPLAY/brochure). Quantitative competitor comparisons are qualitative because all four key category metrics fail the 60% coverage threshold. Category-level observations are from the May 2026 category-benchmarks file. Refresh trigger: re-run when critical-illness category PDF coverage exceeds 60% on the four key metrics.
STRUCTURAL DIMENSIONS
PRODUCT TYPE
Category typical:Renewable- term CI is the dominant agency-channel structure (5/10/15-yr terms with re-underwriting at renewal).
CRISTAL Prime:Fixed-term endowment (15/20/25 yrs; no re-underwriting; ends at term).
Read:Structurally distinctive. The fixed long-term endowment design with return of premium is not common among major agency CI products.
CI STAGING
Category typical:Premium- tier agency CI products increasingly offer staged payouts (early-stage + major- stage + premium waiver), per the Allianz Critical+ pattern documented in the category-benchmarks observations.
CRISTAL Prime:Single-event payout (100% SA + 20% top-up cap Rp 200M). One claim ends the policy.
Read:Below the staged-CI premium-tier standard. Materially weaker on early-stage cover. One of CRISTAL Prime's biggest structural gaps versus the premium peer set.
CI CONDITIONS COUNT
Category typical:Premium- tier agency CI products catalogue 70–100+ conditions; mass-market CI products list 30–60. Sample-of-9 coverage in category data is below threshold for a hard benchmark.
CRISTAL Prime:66 conditions (4 of which sunset at insured age 18).
Read:Mid-pack count. Not the differentiator; staging is the gap.
PREMIUM WAIVER AFTER
CI DIAGNOSIS
Category typical:Premium- tier products bundle CI premium waiver into the base or offer it as a named rider.
CRISTAL Prime:None. Policy terminates on CI claim.
Read:Structural gap versus premium tier. CRISTAL Prime is one-and-done.
RETURN OF PREMIUM AT
MATURITY
Category typical:Booster / return-of-premium tail benefits are increasingly standard for premium-tier CI (per category observa- tions). Tail multiples vary by product.
CRISTAL Prime:120% / 135% / 150% of total premiums paid (depending on 15/20/25- year term selection).
Read:This is CRISTAL Prime's lead structural feature. Return-of-premium with explicit guaranteed multiples — a strong emotional draw for "premi tidak hangus" customers.
DEATH BENEFIT (DURING TERM)
Category typical:Standalone CI products are CI-first with token death benefit; CI-attached whole-life bundles offer full life cover.
CRISTAL Prime:120%/135%/ 150% of total premiums paid — i.e., early payout of the return-of-premium tail. Roughly 25% of sum assured in the illustrated sample case. Not life insurance.
Read:Standard for a standalone CI product — but agents must explicitly flag this to customers to avoid mis-selling as life cover.
COVERAGE TERMS AVAILABLE
Category typical:5/10/15-yr renewable terms dominate agency CI.
CRISTAL Prime:15/20/25-yr fixed term (3, 5, or 10-yr PPT options).
Read:Longer fixed-term commitment than category norm; suits buyers who want certainty over flexibility.
CURRENCY
Category typical:IDR-only is the agency-CI default.
CRISTAL Prime:IDR only.
Read:No differentiation here.
CHANNEL DESIGN
Category typical:Agency channel for the affluent CI segment.
CRISTAL Prime:Agency (keagenan). Consistent with category.
ECONOMIC DIMENSIONS
PREMIUM RANGE
CRISTAL Prime:Rp 3.3M minimum annual / Rp 300K monthly. Sample case (31yo male, Rp 500M SA, 25-yr term, 5-yr PPT) = Rp 16.445M/yr. Category premium-table coverage is below threshold (17%) so a direct percentile placement is unreliable — qualitative
read:in the mid-affluent band.
CI BENEFIT MULTIPLE
CRISTAL Prime:~7.3x total premium in the illustrated sample (Rp 600M payout / Rp 82.2M total premium). Strong when CI strikes early; degrades over time as opportunity cost rises.
EARLY SURRENDER VALUE
CRISTAL Prime:0% in years 1–3. Reaches ~50% by year 15 and 150% by year 25.
Read:Consistent with endowment economics — not designed for early exit.
POSITIONING SUMMARY
CRISTAL Prime's structural
identity is "CI endowment with
guaranteed return of premium."
The return-of-premium tail is
the strongest single feature
and the primary emotional
hook for "premi tidak hangus"
customers.
Against the premium-tier
agency CI category — Allianz
Critical+, Flexi CI on whole-
life base, TMLI tm-ci-guard
(publishing-gap B set), and
comparable Prudential / AIA
staged-CI products — CRISTAL
Prime is materially weaker on
three dimensions
no staging,
no premium waiver after
diagnosis, and term-limited
cover that expires at the
peak-incidence age window.
For Legacy Income agents the
strategic implication is
clear
do not fight the
return-of-premium feature
on its own terms. Reframe to
staging, waiver, and lifetime
cover — three dimensions
where Allianz wins on
structural merit and where
the customer's actual
exposure (early-stage
cancer at age 55, second
CI event, post-diagnosis
premium burden) is best
served by the Allianz
architecture.
6. Field Talking Points (EN + ID)
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
These are positioning talking points for the Legacy Income agent when a prospect surfaces CRISTAL Prime or asks how Allianz compares.
Opening — establish the right frame
“I see you’ve been looking at CRISTAL Prime. It’s a real product with a clear feature — premium back if nothing happens. Let me show you how Allianz handles the same risk, and then you can decide which structure fits your situation. Two different philosophies, both valid; the question is which one matches what you actually need.”
“Saya lihat Bapak/Ibu sedang melihat CRISTAL Prime. Ini produk yang nyata dengan satu fitur yang jelas — premi kembali kalau tidak ada klaim. Saya tunjukkan dulu bagaimana Allianz menangani risiko yang sama, lalu Bapak/Ibu bisa pilih struktur mana yang cocok. Dua filosofi yang berbeda, dua-duanya valid; pertanyaannya struktur mana yang sebenarnya pas dengan kebutuhan Bapak/Ibu.”
Structural value prop — staging matters
“The thing CRISTAL Prime doesn’t have, and Allianz Critical+ does, is staging. Cancer at stage 1, stage 2, stage 3, stage 4 — they are not the same event medically and they shouldn’t be the same event financially. Allianz pays at early-stage when you can still work but treatment is starting. CRISTAL Prime waits until the formal CI definition is met, then pays once, and the policy ends. If you survive a stage-1 cancer, your CI policy is also done — even though your risk of a second event is now higher than before.”
“Yang tidak ada di CRISTAL Prime, dan ada di Allianz Critical+, adalah staging. Kanker stadium 1, stadium 2, stadium 3, stadium 4 — secara medis ini bukan satu peristiwa yang sama, dan secara finansial seharusnya juga tidak sama. Allianz bayar di tahap awal saat Bapak/Ibu masih bisa kerja tapi pengobatan sudah dimulai. CRISTAL Prime menunggu sampai definisi CI formal terpenuhi, lalu bayar sekali, dan polis berakhir. Kalau Bapak/Ibu sembuh dari kanker stadium 1, polis CI juga berakhir — padahal risiko kena yang kedua justru lebih tinggi.”
Why early-stage CI matters even before major CI
“Most cancer in Indonesia is now caught earlier than 10 years ago — screening is better. But treatment is also more expensive and longer. A stage-1 breast cancer in 2026 means chemo for months, lost income, family disruption, before you ever get to the official ‘critical illness’ definition that CRISTAL Prime pays on. Early-stage CI is not a nice-to-have anymore. It’s the realistic shape of the risk.”
“Kebanyakan kanker di Indonesia sekarang ketahuan lebih awal dibanding 10 tahun lalu — screening makin baik. Tapi pengobatan juga lebih mahal dan lebih lama. Kanker payudara stadium 1 di 2026 artinya kemoterapi berbulan-bulan, kehilangan penghasilan, keluarga terganggu, sebelum Bapak/Ibu sampai ke definisi ‘penyakit kritis’ resmi yang dibayar CRISTAL Prime. Early-stage CI bukan fitur tambahan lagi. Itu bentuk risiko yang realistis.”
Close — the structural choice
“CRISTAL Prime gives you premium back if nothing happens. Allianz gives you cover for life, payment at every stage, and your policy keeps protecting you if you survive the first event. Both have a cost. The question is which trade is the one you want — money back if you’re lucky, or coverage at every step if you’re not.”
“CRISTAL Prime mengembalikan premi kalau tidak ada klaim. Allianz memberi perlindungan seumur hidup, pembayaran di setiap stadium, dan polis tetap melindungi kalau Bapak/Ibu sembuh dari event pertama. Dua-duanya ada biayanya. Pertanyaannya trade-off mana yang Bapak/Ibu mau — uang kembali kalau beruntung, atau perlindungan di setiap tahap kalau tidak.”
—
7. Top 5 Customer Objections + Handling
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
1. “BPJS / asuransi kesehatan saya sudah tanggung kanker dan jantung — buat apa CI?”
Customer “My BPJS / health insurance already covers cancer and heart treatment — why do I need CI?”
Don't say “BPJS isn’t enough.” — fights the customer and is not always true.
Don't say “BPJS tidak cukup.”
Do say “BPJS and your hospital insurance reimburse the hospital — they pay the bill. CI pays you. When cancer is diagnosed, the bill isn’t the only problem. You can’t work for 6–12 months. Your spouse may need to stop working to care for you. Your children’s school fees still arrive. CI cash gives you the freedom to focus on recovery without negotiating with the bank. It’s the income-protection layer that BPJS doesn’t touch.”
Do say “BPJS dan asuransi rumah sakit Bapak/Ibu menggantikan biaya rumah sakit — mereka bayar tagihan. CI bayar Bapak/Ibu langsung. Saat kanker terdiagnosis, tagihan bukan satu-satunya masalah. Bapak/Ibu tidak bisa kerja 6–12 bulan. Pasangan mungkin harus berhenti kerja untuk merawat. SPP anak tetap datang. Uang CI memberi kebebasan untuk fokus sembuh tanpa harus negosiasi dengan bank. Ini lapisan proteksi penghasilan yang tidak disentuh BPJS.”
—
2. “Saya sehat, kenapa harus beli CI sekarang?”
Customer “I’m healthy — why buy CI now?”
Don't say “Because you might get sick.” — fear-based, weak, and the customer will resist.
Don't say “Karena bisa sakit nanti.”
Do say “Exactly because you’re healthy now. CI policies have a pre-existing condition exclusion — anything that shows up between today and when you buy is excluded forever. Wait two years, get diagnosed with elevated cholesterol or a thyroid nodule, and either the premium loads heavily or that condition is permanently excluded. The cheapest, cleanest CI policy you’ll ever buy is the one you buy while everything is still normal on paper.”
Do say “Justru karena Bapak/Ibu sehat sekarang. Polis CI ada exclusion untuk pre-existing condition — apapun yang muncul antara hari ini dan saat Bapak/Ibu beli, di-exclude selamanya. Tunggu dua tahun, lalu ada kolesterol tinggi atau nodul tiroid, lalu premi naik signifikan atau kondisi itu di-exclude permanen. Polis CI paling murah dan paling bersih yang pernah Bapak/Ibu beli, adalah yang dibeli saat semua masih normal di atas kertas.”
—
3. “Premi mahal.”
Customer “The premium is expensive.”
Don't say “Tidak mahal kok.” — fights the customer.
Don't say “Tidak mahal kok.”
Do say “Let’s compare carefully. CRISTAL Prime in the sample case is Rp 16.4 juta per year for 5 years — Rp 82 juta total. Allianz Critical+ for the same age and sum assured is typically lower per year because you’re paying for the cover, not for the return-of-premium tail. The premium you pay in CRISTAL Prime is partly insurance and partly forced savings. If you want pure protection at the lowest premium, Allianz wins. If you want the cash-back feature and you’re willing to pay for it, that’s a valid choice — but understand you are paying for it.”
Do say “Mari kita bandingkan dengan jelas. CRISTAL Prime di sample case adalah Rp 16,4 juta per tahun selama 5 tahun — totalnya Rp 82 juta. Allianz Critical+ untuk usia dan UP yang sama biasanya lebih rendah per tahun karena Bapak/Ibu bayar untuk perlindungannya, bukan untuk fitur pengembalian premi. Premi di CRISTAL Prime sebagian asuransi, sebagian tabungan paksa. Kalau Bapak/Ibu mau proteksi murni dengan premi terendah, Allianz menang. Kalau Bapak/Ibu mau fitur cash-back dan siap bayar untuknya, itu pilihan yang valid — tapi pahami bahwa Bapak/Ibu memang membayarnya.”
—
4. “Kalau saya tidak pernah klaim, premi saya hangus — itu yang saya tidak suka.”
Customer “If I never claim, my premium is wasted — that’s what I don’t like.”
Don't say “Insurance isn’t supposed to give money back.” — sounds dismissive.
Don't say “Asuransi memang seperti itu.”
Do say “I understand the feeling. Let me reframe it. Your house insurance doesn’t give your premium back at the end of the year — but you don’t think of it as money wasted, because you slept safely all year. CI is the same: the value is the protection during your earning years. That said, if return-of-premium is genuinely the dealbreaker, CRISTAL Prime offers it; the cost is no staging, no waiver after diagnosis, and cover that ends at age 55–60 when CI risk is climbing fastest. That trade-off is real. The question is: do you want money back if you’re lucky, or coverage at every step if you’re not?”
Do say “Saya mengerti perasaannya. Saya coba bingkai ulang. Asuransi rumah tidak mengembalikan premi di akhir tahun — tapi Bapak/Ibu tidak menganggapnya uang yang hangus, karena Bapak/Ibu tidur tenang sepanjang tahun. CI sama: nilainya ada di perlindungan selama tahun-tahun produktif. Namun kalau memang pengembalian premi itu syarat mati, CRISTAL Prime memang menawarkannya; biayanya adalah tidak ada staging, tidak ada waiver setelah diagnosis, dan perlindungan berakhir di usia 55–60 saat risiko CI justru sedang naik tertinggi. Trade-off itu nyata. Pertanyaannya: mau uang kembali kalau beruntung, atau perlindungan di setiap tahap kalau tidak.”
—
5. “Saya tidak percaya asuransi — mereka selalu cari cara untuk tidak bayar.”
Customer “I don’t trust insurance — they always find a way not to pay.”
Don't say “We always pay claims.” — defensive, the customer has heard this before.
Don't say “Kami selalu bayar klaim.”
Do say “That concern is fair, and the way to address it is in the documents, not in my promise. Every CI condition in the policy has a specific medical definition — for example, ‘cancer’ requires histological confirmation of malignancy, certain in-situ cancers are excluded. I’ll walk through each one before we apply, and we will document any condition in your medical history clearly on the SPAJ. The policies that get denied are almost always policies where something on the medical history was not disclosed. If we declare everything upfront — even the small things — your claim is protected. Insurance pays when the documentation is clean. That’s our job together at the application stage.”
Do say “Kekhawatiran itu wajar, dan cara mengatasinya ada di dokumen, bukan di janji saya. Setiap kondisi CI di polis punya definisi medis yang spesifik — misalnya, ‘kanker’ butuh konfirmasi histologi keganasan, beberapa kanker in-situ di-exclude. Saya akan jelaskan satu per satu sebelum kita apply, dan kita akan dokumentasikan semua riwayat kesehatan Bapak/Ibu dengan jelas di SPAJ. Polis yang klaimnya ditolak hampir selalu polis yang riwayat kesehatannya tidak diungkap. Kalau kita disclose semua di depan — bahkan yang kecil — klaim Bapak/Ibu aman. Asuransi bayar saat dokumentasinya bersih. Itu tugas kita berdua di tahap aplikasi.”
—
8. Compliance Red Flags & Mis-Selling Warnings
CI products carry distinct compliance risk versus life or medical products. These are the seven issues most likely to trigger an OJK complaint, a customer dispute, or a claim repudiation under 2026 conduct rules. Build agent training around avoiding all of them.
-
CI condition definitions are medical, not lay. “Cancer” in CRISTAL Prime (and every comparable CI product) means a histologically confirmed malignant tumour with characteristics defined by the policy. In-situ carcinomas, early-stage prostate cancer, and certain skin cancers are commonly excluded or partially paid. Customer must understand the difference between “the doctor said cancer” and “the policy definition of cancer.” Walk through the top 5 most-claimed conditions (cancer, heart attack, stroke, kidney failure, major surgery) at application stage.
-
Pre-existing condition exclusion plus waiting period. CRISTAL Prime excludes any CI condition arising during the waiting period and any condition that pre-existed the policy (unless specifically endorsed). The RIPLAY references “Masa Tunggu” without specifying a number in the section provided; the policy document itself is the binding source — confirm the exact waiting period with the customer on the SPAJ. Failing to disclose pre-existing conditions is the single most common cause of claim repudiation in Indonesian CI insurance.
-
Single-event payout and policy termination. CRISTAL Prime pays once and ends. Customer must understand: if they survive their first CI event, the policy is over and they have no remaining CI cover from this product. Sell this clearly. Customers who think “I have CI cover for 25 years” but expect cover to continue after a claim will complain at the second event.
-
Death benefit is not life insurance. The CRISTAL Prime death benefit during the term is 120–150% of total premiums paid — typically a fraction of the CI sum assured. Pak Surya’s Rp 500M CI SA pays Rp 123M on death — that is roughly 25% of the CI SA. Selling CRISTAL Prime as a “life and CI combo” is mis-selling. If the customer needs life cover, sell a term life or whole-life policy alongside.
-
CI cash is not medical reimbursement. Customer must understand CRISTAL Prime does not pay for hospital bills, doctor’s fees, chemotherapy, or surgery costs. It pays cash on diagnosis. The customer who thinks “I have CRISTAL Prime, my hospital bill is covered” will complain at the first hospitalisation. Always pair-sell with a medical / hospital policy or confirm the customer has one in force.
-
Return-of-premium framing creates ambiguity risk. “Premi kembali 150%” in marketing language can be heard as “investment return of 50% over 25 years,” which it is not. Over 25 years at any reasonable inflation rate, 150% of nominal premiums is a negative real return. The cash-back is a structural feature, not a yield. Document the customer’s understanding of nominal-vs-real explicitly on the SPAJ.
-
End-of-term re-insurability risk. At policy maturity the customer is 56–85 years old (depending on entry age and term length). At that age CI is hard or impossible to re-purchase. The customer who expects “I’ll just buy new CI cover at 60” needs to understand the practical reality: CI premiums at 60+ are prohibitive and underwriting is restrictive. Frame the term selection explicitly: CRISTAL Prime is CI cover for this window only; legacy CI needs come from a different product.
These compliance points are derived from OJK’s 2026 conduct rules on insurance product distribution (transparency, suitability assessment, documented customer understanding) and from general Indonesian CI product practice. They are not specific to Generali and apply equally to any comparable agency CI sale.
9. Quick-Reference Spec Card
BASIC
Product
CRISTAL Prime
Type
CI endowment with
return-of-premium
tail (single-event
CI payout)
Insurer
PT Asuransi Jiwa
Generali Indonesia
Channel
Agency (keagenan)
Currency
IDR only
Doc ed
RIPLAY Ver. 1.0/X/
2023; Brochure
Ver. 05/Jan/2024
TERMS
Entry age (insured)
31 days – 60 yrs
(nearest birthday)
Entry age (policyholder)
18 – 90 yrs
(nearest birthday)
Policy term
15, 20, or 25 yrs
Premium pay term
3, 5, or 10 yrs
Pay freq
Annual / semi-
annual / quarterly
/ monthly
Min premium
Rp 3.3M annual /
Rp 300K monthly
Min SA
Rp 100,000,000
Max SA
Subject to under-
writing; aggregate
cap Rp 5B adult /
Rp 3B child across
CRISTAL + CRISTAL
Prime; Rp 10B / 5B
across all CI from
insurer
BENEFITS
CI benefit
100% SA + 20% SA
top-up (top-up
capped Rp 200M);
paid once on
covered diagnosis;
policy terminates
CI angioplasty / invasive
coronary item
10% SA (cap Rp 200M)
Death (during term)
120% / 135% / 150%
of total premiums
paid (15/20/25-yr
terms respectively)
Maturity (end of term, no
prior claim)
120% / 135% / 150%
of total premiums
paid (15/20/25-yr
terms respectively)
Child age scaling (CI on
insured under 4)
<1 yr: 20%
1–<2 yrs: 40%
2–<3 yrs: 60%
3–<4 yrs: 80%
>=4 yrs: 100%
CI conditions count
66
(4 conditions
sunset at insured
age 18)
WAITING PERIODS
CI waiting period (Masa
Tunggu)
Specified in policy
document; confirm
on SPAJ. RIPLAY
section references
it as a defined
exclusion window.
Suicide exclusion
1 year from policy
issue / change /
reinstatement
EXCLUSIONS NOTABLE
CI
pre-existing conditions;
waiting-period diagnoses;
self-harm; war; active
participation in unrest;
non-commercial flights;
alcohol/drug-related;
hazardous sports (diving,
skydiving, contact sports,
motor racing, climbing,
caving, boxing); congenital;
psychiatric (unless listed);
HIV/AIDS (unless via the
specific occupational /
transfusion CI codes)
Death
suicide year 1; war;
intentional unlawful acts;
judicial death penalty
POLICY MECHANICS
Grace period
45 calendar days
Cooling off
14 calendar days
from receipt
Reinstatement
Up to 24 months
after lapse
Surrender
Allowed; values
0% Y1–3, ~10%
Y5, ~40% Y10,
~50% Y15, 150%
Y25 (sample
illustration)
Claim notif
CI diagnosis
must be notified
within 30 days
Claim filing
Death claim
within 90 days
of event
Insurer decision SLA
60 working days
after complete
documentation
Payout SLA
30 working days
after decision
SAMPLE CASE
Pak Surya, M-31,
Rp 500M SA,
25-yr term, 5-yr PPT,
Rp 16.445M annual premium.
Total premium
Rp 82.225M
CI payout if claim
Rp 600M
Death benefit during term
Rp 123.3375M
Maturity benefit (year 25)
Rp 123.3375M
10. Action Items for Legacy Income (next 30 days)
CRISTAL Prime is a Generali product. Legacy Income sells Allianz. The actions below are competitive intelligence — equip agents to win against CRISTAL Prime in the field, not to sell it.
-
Build a “CRISTAL Prime vs Allianz Critical+” one-page comparison handout. Side-by-side: staging (Allianz has it, CRISTAL Prime doesn’t), premium waiver after diagnosis (Allianz has it, CRISTAL Prime doesn’t), lifetime cover option (Allianz Flexi CI rider on whole-life base, CRISTAL Prime ends at age 56–85), return of premium (CRISTAL Prime has it, Allianz doesn’t on Critical+). Show both columns honestly. EN+ID. The handout neutralises the “premi tidak hangus” objection by surfacing the structural cost of that feature.
-
Train agents on the “early-stage CI matters” talking point. Specifically: most cancers in Indonesia are now diagnosed earlier than 10 years ago, treatment-cost burden shifts forward, and the customer experience of CI is increasingly stage-1 / stage-2 not stage-4. Single-event CI products like CRISTAL Prime do not pay at early-stage in the way staged-CI products do. Build a 10-minute role-play module around this objection.
-
Identify prospect overlap with Generali HealthCare Solution and GEN MediCare customers. Generali’s medical insurance customers are the natural cross-sell target for CRISTAL Prime. If Legacy Income has agents in markets where these Generali medical products have strong penetration (Jakarta urban, Surabaya, Medan), prepare a counter-pitch script focused on the limitations of single-event CI and the value of staging plus waiver.
-
Add a “death benefit is not life insurance” red-flag check to every CI pitch. When a prospect surfaces CRISTAL Prime or a comparable return-of-premium CI product, the agent’s first qualifying question must be: “Do you have separate life insurance?” If no, the conversation must include LegacyPro or a term-life layer alongside any CI discussion. This protects the customer and the agency from mis-selling exposure.
-
Refresh trigger. Re-run this brief when the critical-illness category PDF coverage exceeds 60% on the four key metrics (annual premium, sum assured, CI conditions count, policy term). Until then, the qualitative observations plus direct PDF reading carry the analysis. Set a recheck flag for August 2026.
This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official Generali Cristal Prime RIPLAY and brochure as downloaded 2026-04-29; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.
Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.